The coronavirus epidemic in Russia may end by spring.

This was stated by the head of Rospotrebnadzor Anna Popova in the film Naili Asker-zade on the TV channel "Russia 1".

“Well, it will be over by the spring, if we try, it may end earlier.

Depends on everyone today ”- TASS quotes Popova.

In turn, Moscow Mayor Sergei Sobyanin noted that the acute period should end in a few months.

“I think we will fight COVID-19 for a long time, but the most acute period should end in a few months,” he said.

Popova also said that the COVID-19 coronavirus vaccine is not needed for those who already have antibodies.

According to her, if antibodies have not developed after an illness, you need to consult a doctor who will decide whether to get vaccinated. 

“The doctor must determine, firstly, why they are not there after the illness, whether it was the same illness that we are talking about,” she said.

According to the director of the center.

Gamalea by Alexander Gintsburg, protective antibodies and memory cells may not form in people with immunodeficiency or under stress.

“No vaccine guarantees absolute protection.

The remaining 5% are those people who, for some reason, did not respond with the formation of antibodies and natural memory cells to the administration of the vaccine, ”he added.

As noted by the director of the "Vector" center Rinat Maksyutov, similar to SARS-CoV-2, which do not pose a danger, were found.

According to him, they differ from the new coronavirus by no more than 1%.

He also stressed that immunity from COVID-19 after receiving the EpiVacCorona vaccine is maintained for at least six months.

Over the past day, 28,209 new cases of coronavirus infection were detected in Russia (in the two days preceding this, the figure was 28,552 and 28,214).

The total number of recorded episodes of COVID-19 in the country since the beginning of the epidemic has reached 2,819,429, over 514,000 of them remain active (18.24%).

The largest number of new cases of coronavirus was detected in Moscow (6459), St. Petersburg (3754), Moscow (1514), Nizhny Novgorod (502) and Sverdlovsk (405) regions.

For the entire time, 2,254,742 patients have recovered in the country (26,109 - over the past day).

From complications that developed against the background of coronavirus infection and concomitant diseases, 50,347 people died (585 - per day).

According to Rospotrebnadzor, more than 85.4 million tests for COVID-19 have been carried out in the country, about 599 thousand people remain under medical supervision.

  • RIA News

  • © Kirill Braga

Meanwhile, worldwide, the number of reported cases of COVID-19 has exceeded 75.6 million, according to data from Johns Hopkins University.

The countries most affected by the pandemic are the United States (17.4 million cases of coronavirus), India (10 million) and Brazil (7.1 million).

These three states recorded the largest number of deaths from coronavirus infection - 313.5 thousand in the United States, 185 thousand in Brazil, 145 thousand in India.

We add that the US Food and Drug Administration approved the application of the American company Moderna to register its COVID-19 vaccine.

Now the drug is approved for use in the vaccination of the population of the United States of America over the age of 18 years.

At the same time, on the eve of the Moderna company destroyed 400 thousand doses of vaccine due to problems of "filtration".

Earlier in the United States, a vaccine from BioNTech and Pfizer received approval for use.

It was after being vaccinated with this drug in a Tennessee hospital that one of the nurses lost consciousness.

According to The New York Post, doctors nearby indicated that the incident was not related to components of the vaccine.

We will remind, the Russian vaccine against coronavirus "Sputnik V", developed by specialists of the Center.

Gamalei, became the first registered in the world.

The drug consists of two components to develop a reliable immune response, so vaccination is carried out twice (again - after 21 days).

According to the latest published data, its effectiveness at the final control point after 21 days from the moment the volunteers received the first component is estimated at 91.4%.

At the same time, the effectiveness of the drug against severe cases of the disease reaches 100%.

Later, the deputy director of the center.

Gamalei on scientific work Denis Logunov explained that the peak of the immune response falls on the 42nd day after the first injection, so the assessment of the effectiveness of "Sputnik V" can later be revised upwards.